A detailed history of Css LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Css LLC holds 263 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
263
Previous 38,750 99.32%
Holding current value
$0
Previous $702,000 99.43%
% of portfolio
0.0%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$17.36 - $19.34 $668,134 - $744,338
-38,487 Reduced 99.32%
263 $4,000
Q1 2024

May 15, 2024

BUY
$8.6 - $18.18 $333,250 - $704,475
38,750 New
38,750 $702,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.